- Home
- BIVI vs ICAD Comparison
BIVI vs ICAD Comparison
Compare BIVI & ICAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIVI
- ICAD
- Stock Information
- Founded
- BIVI 2013
- ICAD 1984
- Country
- BIVI United States
- ICAD United States
- Employees
- BIVI N/A
- ICAD N/A
- Industry
- BIVI Biotechnology: Pharmaceutical Preparations
- ICAD Medical/Dental Instruments
- Sector
- BIVI Health Care
- ICAD Health Care
- Exchange
- BIVI Nasdaq
- ICAD Nasdaq
- Market Cap
- BIVI 45.1M
- ICAD 40.8M
- IPO Year
- BIVI N/A
- ICAD 1986
- Fundamental
- Price
- BIVI $3.11
- ICAD $1.54
- Analyst Decision
- BIVI Strong Buy
- ICAD
- Analyst Count
- BIVI 2
- ICAD 0
- Target Price
- BIVI $40.00
- ICAD N/A
- AVG Volume (30 Days)
- BIVI 3.3M
- ICAD 281.0K
- Earning Date
- BIVI 11-13-2024
- ICAD 11-13-2024
- Dividend Yield
- BIVI N/A
- ICAD N/A
- EPS Growth
- BIVI N/A
- ICAD N/A
- EPS
- BIVI N/A
- ICAD N/A
- Revenue
- BIVI N/A
- ICAD $18,940,000.00
- Revenue This Year
- BIVI N/A
- ICAD $13.15
- Revenue Next Year
- BIVI N/A
- ICAD $24.28
- P/E Ratio
- BIVI N/A
- ICAD N/A
- Revenue Growth
- BIVI N/A
- ICAD 10.03
- 52 Week Low
- BIVI $1.04
- ICAD $1.18
- 52 Week High
- BIVI $56.54
- ICAD $2.65
- Technical
- Relative Strength Index (RSI)
- BIVI 56.34
- ICAD 40.50
- Support Level
- BIVI $2.87
- ICAD $1.45
- Resistance Level
- BIVI $3.85
- ICAD $1.69
- Average True Range (ATR)
- BIVI 0.39
- ICAD 0.17
- MACD
- BIVI 0.01
- ICAD -0.07
- Stochastic Oscillator
- BIVI 51.32
- ICAD 9.28
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.
About ICAD iCAD Inc.
icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.